Pharma Registration in Bahrain: Fast-Track Market Access

Welcome to this module on Reference Countries in Medical Device Regulation. In this section, we will explore the global and regional reference systems used by the National Health Regulatory Authority Bahrain (NHRA) to support regulatory decision-making.

Understanding which countries are considered reference authorities is essential, as NHRA often relies on approvals and standards from recognized regulatory bodies when evaluating medical devices. This includes both European countries and members of the Gulf Cooperation Council (GCC), each playing a key role in shaping regulatory pathways.

In this module, we will identify these reference countries, understand their significance, and learn how their approvals and certifications can impact the registration process in Bahrain.

By the end of this module, you will be able to:

• Understand the concept of reference countries in regulatory frameworks.

• Identify the European and GCC countries recognized by NHRA.

• Recognize how reference approvals facilitate and influence registration pathways.

• Apply this knowledge to optimize regulatory strategies.

This module is designed for regulatory affairs professionals, medical device manufacturers, and industry specialists aiming to streamline their registration process in Bahrain.

Let’s begin by exploring the global and regional reference systems that support medical device regulation

Welcome to this module, where we will build the core backbone of regulatory affairs—starting with the site dossier as the foundation, followed by the product dossiers as its branches. A strong regulatory structure begins with a properly registered and approved manufacturing site.

In the Kingdom of Bahrain, site registration with the National Health Regulatory Authority Bahrain is a mandatory first step before proceeding with product registration. Without an approved site, product submissions cannot move forward, making this stage critical to the entire regulatory pathway.

In this module, we will explore how to prepare and structure the site dossier, understand its requirements, and see how it supports multiple product registrations. You will also learn how the site dossier connects to and supports the development of individual product dossiers.

By the end of this module, you will be able to:

• Understand the importance of site registration as the starting point.

• Prepare a compliant site dossier.

• Recognize the relationship between site and product dossiers.

• Build a strong regulatory foundation for successful submissions.

This module is designed for regulatory affairs professionals, manufacturers, and industry specialists aiming to establish a solid starting point for medical device registration.

Let’s begin by building the foundation—starting with the site dossier and setting the stage for successful product registration.

Welcome to this module, where we take the very first step in the registration process: medical device classification. Classification is the foundation of the entire regulatory pathway, as it determines the level of risk, required documentation, and approval route for each product.

In the Kingdom of Bahrain, classification is defined and overseen by the National Health Regulatory Authority Bahrain, making it a critical starting point for any successful registration strategy.

In this section, we will explore how to classify medical devices correctly, understand the criteria used, and see how classification directly impacts the regulatory requirements and submission process.

By the end of this module, you will be able to:

• Understand the importance of classification as the first step in registration.

• Identify the classification criteria for medical devices.

• Determine the appropriate regulatory pathway based on classification.

• Build a strong foundation for all subsequent regulatory activities.

This module is designed for regulatory affairs professionals, medical device manufacturers, and industry specialists beginning their journey in medical device registration.

Let’s start by mastering classification—the key decision point that shapes the entire regulatory pathway.

Welcome to this module, where you will be introduced to the actual medical device registration process. This section marks the transition from foundational concepts to the practical regulatory pathway required to bring a product to market.

In this module, we will explore the official guidelines issued by the National Health Regulatory Authority Bahrain, which form the basis for preparing compliant submission dossiers. Understanding these guidelines is essential, as they define the requirements, structure, and expectations for successful registration.

By mastering these guidelines, you will be equipped to prepare accurate and complete dossiers in the upcoming modules.

By the end of this module, you will be able to:

Understand the medical device registration process in Bahrain.

Interpret the key regulatory guidelines and requirements.

Apply these guidelines to prepare submission dossiers effectively.

Build a strong foundation for successful regulatory submissions.

This module is designed for regulatory affairs professionals, medical device manufacturers, and industry specialists preparing for practical registration activities.

Let’s begin by exploring the registration process and the guidelines that will guide your dossier preparation.

In this section, we will practice the CTD and its transition to the eCTD , with great focus on M1 and its checklist

Welcome to this module, where we will build together the core of the CTD/eCTD for pharmaceutical products. This core structure represents the globally accepted standard for regulatory submissions, forming the backbone of any successful pharmaceutical registration dossier.

In this section, we will focus on the essential modules and their organization, ensuring that all scientific and technical data are presented in a clear, structured, and compliant manner. Mastering this core structure is critical for meeting international regulatory expectations and facilitating efficient review by health authorities.

By the end of this module, you will be able to:

• Understand the core structure of the CTD/eCTD.

• Identify the key modules and their contents.

• Organize data according to globally accepted regulatory standards.

• Build a strong and compliant foundation for pharmaceutical submissions.

This module is designed for regulatory affairs professionals, pharmacists, and pharmaceutical industry specialists aiming to develop expertise in preparing high-quality regulatory dossiers.

Let’s begin by building the core CTD/eCTD structure and mastering the foundation of global pharmaceutical submissions.

I prefer this response

Welcome to this module on the CTD to eCTD Transition, focusing on one of the most critical stages in electronic submissions—the baseline submission. This stage represents the bridge between traditional dossier formats and fully structured electronic submissions.

In this section, we will take a hands-on approach to managing the transition from CTD to eCTD, using the baseline submission as a practical and effective tool. You will learn how to convert existing dossiers into an eCTD-compliant format while maintaining structure, traceability, and regulatory compliance.

Understanding the baseline submission is essential, as it sets the foundation for all future lifecycle activities, including variations, renewals, and updates.

By the end of this module, you will be able to:

• Understand the concept and importance of baseline submission.

• Manage the transition from CTD to eCTD effectively.

• Prepare a baseline eCTD submission from existing CTD dossiers.

• Ensure compliance with electronic submission requirements.

This module is designed for regulatory affairs professionals, pharmacists, and pharmaceutical industry specialists seeking practical expertise in eCTD transition.

Let’s begin by mastering the baseline submission and successfully transitioning from CTD to eCTD.

Welcome to this module on Practical Dossier Submission and Forms. In this section, we will move into hands-on practice by working through the actual submission forms required for regulatory approval.

You will be guided step by step through each form, understanding its purpose, required information, and specific conditions. This practical approach will help you gain confidence in completing and organizing submission documents accurately and in line with regulatory expectations.

By the end of this module, you will be able to:

• Understand the structure and purpose of each submission form.

• Complete forms with accurate and compliant information.

• Identify the special conditions and requirements for each document.

• Prepare a submission-ready dossier with properly completed forms.

This module is designed for regulatory affairs professionals, pharmacists, and pharmaceutical industry specialists who want to gain practical experience in preparing regulatory submissions.

Let’s begin by working through the submission forms one by one and mastering the practical side of dossier submission.

In this section we will cover all the details of the updated requirement set by NHRA for the eCTD submission